Suparno Chakrbarti is the Director of Bone Marrow Transplant Program, Dharamshila Hospital, Delhi, India, and the President of the Manashi Chakrabarti Foundation (a charity for blood diseases). He was instrumental in setting up the Department of Clinical Haematology at PGIMER. In 1998, he left for the UK to undertake a fellowship in BMT at Birmingham Heartland’s Hospital and Bristol Children’s Hospital for 5 years. During this period his clinical and laboratory research in the field of BMT led to several breakthroughs such as in the field of posttransplant infections and reduced intensity transplantation and use of Campath antibodies in transplant. With over 100 publications in the field and similar number of presentations in international meetings and conferences, he stands as a leading international figure in the field of haematology and BMT. As recognition of his contribution in this field, Dr. Chakrabarti was awarded the fellowship of the Royal College of Pathologists. He has been invited worldwide to talk on these subjects and has been nominated in the expert committee for the European and international bone marrow transplant organizations. He has been on the editorial committee of many international journals and acts as a reviewer for international cancer organizations. Having achieved all possible laurels in the field of BMT, Dr. Chakrabarti has left the job of heading the BMT Unit at St. George’s Hospital in London in order to provide this service to the people of India as he felt the his services should now be dedicated to his own countrymen. Along with Dr Sarita Jaiswal, Dr Chakrabarti initiated the first Haploidentical BMT program in India in 2010. They have developed the program for advanced and high risk leukemia and lymphoma as well as severe aplastic anemia. Having performed over 75 such transplants, they have extended the program to patients with hemoglobinopathies as well.
Biography Updated on 9 November 2015